BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
496 results:

  • 1. Application research of radiomics in colorectal cancer: A bibliometric study.
    Yang L; Wang B; Shi X; Li B; Xie J; Wang C
    Medicine (Baltimore); 2024 Apr; 103(15):e37827. PubMed ID: 38608072
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nomograms integrating the collagen signature and systemic immune-inflammation index for predicting prognosis in rectal cancer patients.
    Yu X; Jiang W; Dong X; Yan B; Xu S; Lin Z; Zhuo S; Yan J
    BJS Open; 2024 Mar; 8(2):. PubMed ID: 38513282
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
    Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
    J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
    Shitara K; Muro K; Watanabe J; Yamazaki K; Ohori H; Shiozawa M; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Mori I; Yamanaka K; Hihara M; Soeda J; Misumi T; Yamamoto K; Yamashita R; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
    Nat Med; 2024 Mar; 30(3):730-739. PubMed ID: 38347302
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
    Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
    EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Demographic and clinico-pathological characteristics of colorectal cancer in Kirkuk governorate, Iraq.
    Arif KB; Said S; Khiro N; Ibrahem S; Al-Ghamdi S
    Hum Antibodies; 2023; 31(4):89-98. PubMed ID: 38217589
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
    Li X; Li J; Li J; Liu N; Zhuang L
    BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prediction of postoperative infectious complications in elderly patients with colorectal cancer: a study based on improved machine learning.
    Tian Y; Li R; Wang G; Xu K; Li H; He L
    BMC Med Inform Decis Mak; 2024 Jan; 24(1):11. PubMed ID: 38184556
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
    Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
    Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incidental findings on staging rectal MRI: clinical significance and outcomes.
    Tang YZ; Alabousi A
    Acta Radiol; 2024 Apr; 65(4):374-382. PubMed ID: 38115675
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]    [Full Text] [Related]  

  • 12. The relationship between systemic inflammatory response, screen detection and outcome in colorectal cancer.
    Johnstone MS; McSorley ST; McMillan DC; Horgan PG; Mansouri D
    Colorectal Dis; 2024 Jan; 26(1):81-94. PubMed ID: 38095280
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of High-Deductible Health Plans and Time to Surgery for Breast and Colon cancer.
    Sheckter CC; Rochlin DH; Rubenstein R; Shamsunder MG; Morris AM; Wagner TH; Matros E
    J Am Coll Surg; 2023 Sep; 237(3):473-482. PubMed ID: 38085770
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study.
    Jiang K; Cao F; Yin L; Hu Y; Zhao X; Huang X; Ma X; Li J; Lu M; Sun Y
    J Endocrinol Invest; 2024 May; 47(5):1251-1260. PubMed ID: 38060154
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [The structure of pathogenic germline variants in colorectal cancer in Moscow patients].
    Semenova AB; Byakhova MM; Makarova MV; Galkin VN; Nemtsova MV; Chernevskiy DK; Danishevich AM; Shatalov VG; Babkina AV; Popova NG; Gadzhieva SM
    Arkh Patol; 2023; 85(6):16-25. PubMed ID: 38010635
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of ICD-10 Clinical Modification Codes for Social Determinants of Health with Surgical Outcomes and Hospital Charges Among cancer Patients.
    Diaz A; Pawlik T
    Ann Surg Oncol; 2024 Feb; 31(2):1171-1177. PubMed ID: 38006529
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Pitz M; Musto G; Galloway K; Lambert P
    Cancer Med; 2023 Dec; 12(23):21465-21479. PubMed ID: 37974380
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Circular RNA ZNF800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer.
    Rengganaten V; Huang CJ; Wang ML; Chien Y; Tsai PH; Lan YT; Ong HT; Chiou SH; Choo KB
    BMC Cancer; 2023 Nov; 23(1):1088. PubMed ID: 37950151
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV.
    Pietrantonio F; Bergamo F; Rossini D; Ghelardi F; De Grandis MC; Germani MM; Barsotti G; Formica V; Frassineti GL; Boscolo G; Cinieri S; Di Donato S; Antonuzzo L; Antoniotti C; Ambrosini M; Piva VM; Nichetti F; Fassan M; Cremolini C; Lonardi S
    Eur J Cancer; 2023 Dec; 195():113396. PubMed ID: 37924647
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Disparities among Black and Hispanic colorectal cancer patients: Findings from the California cancer Registry.
    Mendez JS; Wang R; Liu L; Zhang J; Schmitt SL; Figueiredo J; Lenz HJ; Stern MC
    Cancer Med; 2023 Nov; 12(22):20976-20988. PubMed ID: 37909220
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 25.